ES2095964T3 - Una composicion de excipiente liquida que forma un gel. - Google Patents

Una composicion de excipiente liquida que forma un gel.

Info

Publication number
ES2095964T3
ES2095964T3 ES91920627T ES91920627T ES2095964T3 ES 2095964 T3 ES2095964 T3 ES 2095964T3 ES 91920627 T ES91920627 T ES 91920627T ES 91920627 T ES91920627 T ES 91920627T ES 2095964 T3 ES2095964 T3 ES 2095964T3
Authority
ES
Spain
Prior art keywords
pct
date
gel
forms
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920627T
Other languages
English (en)
Inventor
Anders Carlsson
Conny Bogentoft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of ES2095964T3 publication Critical patent/ES2095964T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

UNA COMPOSICION PORTADORA QUE ES UN LIQUIDO A TEMPERATURA AMBIENTE O POR DEBAJO DE LA MISMA Y FORMA UN GEL O CAPA DE ALTA VISCOSIDAD A TEMPERATURA CORPORAL, QUE COMPRENDE UN ETER DE CELULOSA NO IONICO SOLUBLE EN AGUA CON UN PUNTO DE ENTURBAMIENTO NO SUPERIOR A 40 (GRADOS) C, PREFERENTEMENTE 35 (GRADOS) C, UN SUPERFICIACTIVO CARGADO Y ADITIVOS OPCIONALES EN AGUA. DICHA COMPOSICION PORTADORA PUEDE UTILIZARSE PARA ADMINISTRACION ORAL O LOCAL DE UNA SUSTANCIA FARMACOLOGICAMENTE ACTIVA PARA LA PIEL, MEMBRANA MUCOSA, OJO O CAVIDAD CORPORAL.
ES91920627T 1990-11-22 1991-10-30 Una composicion de excipiente liquida que forma un gel. Expired - Lifetime ES2095964T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003712A SE466134B (sv) 1990-11-22 1990-11-22 Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner

Publications (1)

Publication Number Publication Date
ES2095964T3 true ES2095964T3 (es) 1997-03-01

Family

ID=20380971

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920627T Expired - Lifetime ES2095964T3 (es) 1990-11-22 1991-10-30 Una composicion de excipiente liquida que forma un gel.

Country Status (16)

Country Link
US (1) US5492937A (es)
EP (1) EP0558586B1 (es)
JP (1) JP2694166B2 (es)
AT (1) ATE147273T1 (es)
AU (1) AU660157B2 (es)
CA (1) CA2095728C (es)
DE (1) DE69124109T2 (es)
DK (1) DK0558586T3 (es)
ES (1) ES2095964T3 (es)
FI (1) FI103714B1 (es)
GR (1) GR3022536T3 (es)
IE (1) IE65545B1 (es)
NO (1) NO307816B1 (es)
PT (1) PT99593B (es)
SE (1) SE466134B (es)
WO (1) WO1992009307A1 (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003713L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition
US6440395B1 (en) 1992-06-22 2002-08-27 Barry M. Libin Antiplaque mouth rinse
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) * 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
DE69428120T2 (de) * 1993-04-30 2002-04-11 Eastern Virginia Med School Lokal anwendbares präparat zur reepithelisierung bei andauernden epitheldefekten
FR2710529A1 (fr) * 1993-09-29 1995-04-07 Zirinis Phedon Gel aqueux à usage nasal, pellets, et leur procédé de préparation.
FR2710530B1 (fr) * 1993-09-29 1995-12-22 Phedon Zirinis Gel aqueux à usage nasal, pellets, et leur procédé de préparation.
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
CZ286758B6 (en) 1994-03-21 2000-06-14 Thomsen John Brown Pharmaceutical preparation in the form of a gel for treating skin diseases
CA2172373C (en) * 1994-08-30 1999-03-16 Bhagwati P. Kabra Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
US5827835A (en) * 1994-08-30 1998-10-27 Alcon Laboratories, Inc. Thermally-gelling emulsions
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
US6117419A (en) * 1996-09-16 2000-09-12 Vernice; Joseph James Delivery system for oil soluble actives in cosmetic/personal care products
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6108850A (en) * 1997-06-03 2000-08-29 Mclaughlin; Gerald Accelerated method and instrumentation for whitening teeth
GB9712272D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
GB9712271D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
US6537537B2 (en) 1997-06-12 2003-03-25 The Procter & Gamble Company Water-in-silicone emulsion cosmetic compositions
US6316010B2 (en) 1997-06-12 2001-11-13 The Procter & Gamble Company Cosmetic compositions
GB9712269D0 (en) * 1997-06-12 1997-08-13 Procter & Gamble Cosmetic composition
US6669927B2 (en) 1998-11-12 2003-12-30 3M Innovative Properties Company Dental compositions
US6312666B1 (en) * 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of whitening teeth
US6312667B1 (en) 1998-11-12 2001-11-06 3M Innovative Properties Company Methods of etching hard tissue in the oral environment
US6156349A (en) * 1998-12-14 2000-12-05 Steinbach, Pylant And Herman, L.L.C. Method of treating HIV infection with suppository containing mammalian liver extract
US6350472B1 (en) 1998-12-14 2002-02-26 Steinbach, Pylant, And Hermann, L.L.C. Method of treating HIV infection with transdermal gel containing mammalian liver extract
US6537575B1 (en) * 1999-07-30 2003-03-25 The University Of Chicago Synthetic biological membrane with self organizing properties
JP2001329183A (ja) * 2000-05-22 2001-11-27 Yuichi Mori ゲル化性組成物
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
JP2002154989A (ja) * 2000-11-14 2002-05-28 Lion Corp 眼科用組成物、及び生体粘膜への薬物の滞留性向上組成物
US6620405B2 (en) 2001-11-01 2003-09-16 3M Innovative Properties Company Delivery of hydrogel compositions as a fine mist
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
AU2003264498A1 (en) * 2002-09-18 2004-04-08 Wakamoto Pharmaceutical Co., Ltd. Transparent and reversibly heat-gelling aqueous compositions
US6953775B2 (en) * 2002-10-10 2005-10-11 Burruano Brid T Composition for synthetic cervical mucus formulation
JP2004271361A (ja) * 2003-03-10 2004-09-30 Seiko Instruments Inc 携帯時計
US7051654B2 (en) * 2003-05-30 2006-05-30 Clemson University Ink-jet printing of viable cells
SE0302924D0 (sv) * 2003-11-05 2003-11-05 Camurus Ab Pharmaceutical composition having a cationic excipient
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US20050222539A1 (en) * 2004-03-30 2005-10-06 Pediamed Pharmaceuticals, Inc. Automatic injection device
US8128952B2 (en) * 2005-01-12 2012-03-06 Clemson University Research Foundation Ligand-mediated controlled drug delivery
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
US8480651B2 (en) * 2007-08-02 2013-07-09 Covidien Lp Cannula system
FR2940761B1 (fr) * 2009-01-07 2012-12-28 Polymerexpert Sa Composition anti-ronflement contenant un polymere thermogelifiant
US8916171B2 (en) 2010-04-27 2014-12-23 Topical Sinus Therapeutics, Inc. Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
WO2011162965A1 (en) * 2010-06-24 2011-12-29 3M Innovative Properties Company Aqueous composition suitable for intra-oral scanning methods
GB201105408D0 (en) * 2011-03-30 2011-05-11 Glaxo Group Ltd Composition
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
CN102448496B (zh) * 2011-06-22 2015-04-15 江苏德达医药科技有限公司 含碘和类固醇的药物组合物及其用于治疗鼻炎疾病的用途
CA2842837A1 (en) 2011-07-26 2013-01-31 The Curators Of The University Of Missouri Engineered comestible meat
GB201121300D0 (en) * 2011-12-12 2012-01-25 Glaxo Group Ltd Novel composition
ES2375784B1 (es) * 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
EP3021835B1 (en) * 2013-07-17 2017-05-10 Dow Global Technologies LLC Composition for application to a mucosa comprising a hydroxyalkyl methylcellulose
WO2015038988A1 (en) 2013-09-13 2015-03-19 Modern Meadow, Inc. Edible and animal-product-free microcarriers for engineered meat
EP3102043A4 (en) 2014-02-05 2017-08-09 Modern Meadow, Inc. Dried food products formed from cultured muscle cells
PL3822294T3 (pl) * 2014-06-30 2024-02-19 Basf South East Asia Pte. Ltd. Nowe środki zapobiegające zbrylaniu do wytwarzania poliizobutylenu
JP2017524053A (ja) * 2014-08-15 2017-08-24 ダウ グローバル テクノロジーズ エルエルシー エチルセルロース分散体及び粉末
WO2017053433A1 (en) 2015-09-21 2017-03-30 Modern Meadow, Inc. Fiber reinforced tissue composites
ES2806990T3 (es) 2016-02-15 2021-02-19 Modern Meadow Inc Procedimiento para fabricar un material biofabricado que contiene fibrillas de colágeno
SE1750680A1 (en) 2017-05-30 2018-12-01 Peptonic Medical Ab Composition for treating or preventing climacteric disorders
AU2018253595A1 (en) 2017-11-13 2019-05-30 Modern Meadow, Inc. Biofabricated leather articles having zonal properties
MX2021008462A (es) 2019-01-17 2021-08-19 Modern Meadow Inc Materiales de colageno estratificados y metodos para fabricarlos.
US20240041916A1 (en) 2020-04-28 2024-02-08 Peptonic Medical Ab Composition for treating and/or preventing vestibulodynia

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA529401A (en) * 1956-08-21 D. Klug Eugene Modified ethyl cellulose and its method of preparation
US4042719A (en) * 1972-02-25 1977-08-16 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt Compositions of low calory content
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US5126332A (en) * 1986-09-01 1992-06-30 Terumo Kabushiki Kaisha Food compositions for the prevention of overeating
SE461396B (sv) * 1988-05-24 1990-02-12 Berol Kemi Ab Saett att vid temperaturhoejning motverka viskositetsnedgaang alternativt aastadkomma viskositetsoekning hos ett vattenbaserat system innehaallande en polymer som viskositetsgivare
EP0386960A3 (en) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
SE9003713L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande dietfiberkomposition

Also Published As

Publication number Publication date
US5492937A (en) 1996-02-20
IE913819A1 (en) 1992-06-03
NO931852D0 (no) 1993-05-21
FI103714B (fi) 1999-08-31
IE65545B1 (en) 1995-11-01
CA2095728A1 (en) 1992-05-23
NO307816B1 (no) 2000-06-05
SE9003712L (sv) 1992-01-07
PT99593A (pt) 1992-10-30
FI103714B1 (fi) 1999-08-31
SE9003712D0 (sv) 1990-11-22
PT99593B (pt) 2000-08-31
GR3022536T3 (en) 1997-05-31
NO931852L (no) 1993-07-21
AU8954391A (en) 1992-06-25
EP0558586A1 (en) 1993-09-08
FI932325A (fi) 1993-05-21
DK0558586T3 (da) 1997-01-27
WO1992009307A1 (en) 1992-06-11
SE466134B (sv) 1992-01-07
ATE147273T1 (de) 1997-01-15
JPH06505705A (ja) 1994-06-30
DE69124109D1 (de) 1997-02-20
CA2095728C (en) 2002-01-22
FI932325A0 (fi) 1993-05-21
JP2694166B2 (ja) 1997-12-24
AU660157B2 (en) 1995-06-15
DE69124109T2 (de) 1997-06-19
EP0558586B1 (en) 1997-01-08

Similar Documents

Publication Publication Date Title
ES2095964T3 (es) Una composicion de excipiente liquida que forma un gel.
IT1248702B (it) Agente antitussivo e mucoregolatore,sua preparazione e composizioni farmaceutiche
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
DE69105106T2 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
SE9601421D0 (sv) New composition
FI932324A (fi) Gelbildande flytande naeringsfibersammansaettning
ITRM920310A1 (it) Impiego di inibitori di aromatosi per contraccezione in primati femmine senza influire sul ciclo mestruale
DK0727996T3 (da) Fendazolformuleringer
GB9227123D0 (en) Method
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
JPS57159707A (en) Dissolution of perfume in water
ES2087863T3 (es) Composicion limpiacristales.
ES2166007T3 (es) Procedimiento para la preparacion de antraquinonas sustituidas.
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
GR77250B (es)
HU214991B (hu) Komplett in vitro Lactobacillus tápközeget tartalmazó gyógyszerkészítmény és eljárás előállítására
IT8967594A0 (it) Procedimento per la produzione di una miscela acquosa di lisin metil 4 2 tienilcarbonil fenilacetato perimpiego locale nella medicina oftalmica
IT1241449B (it) Preparato antiinfiammatorio ad uso oftalmico.
KR920007620A (ko) 실리마린 및 약학 또는 화장품조성물의 용해방법
IT1240352B (it) Formulazioni liposomiali di farmaci mucosecretolitici e/o broncopolmonari per applicazione aerosolica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 558586

Country of ref document: ES